Species differences in blood profiles, metabolism and excretion of14C-propofol after intravenous dosing to rat, dog and rabbit
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 21 (10) , 1243-1256
- https://doi.org/10.3109/00498259109043199
Abstract
1. Bolus i.v. doses of 14C-propofol (7–10 mg/kg) to rat, dog and rabbit, or an infusion dose (0.47mg/kg per min for 6h) to dog were eliminated primarily in urine (60–95% dose); faecal elimination (13–31%) occurred for rat and dog, but was minimal (14C concentrations were maximal (8–30 μg equiv./ml) at 2–15 min; these declined rapidly during the 0–2 h period and thereafter more slowly. Propofol concentrations were maximal (4–16 μ/ml) at 2 min and the profiles were best fitted by a tri-exponential (rat and dog) or bi-exponential (rabbit) equation. Duration of sleep ranged from 5 to 8 min. 3. Infusion of 1C-propofol in dog gave a blood 14C concentration of 117 μg equiv./ml at the end of the 6 h infusion period; this declined at a similar rate to that after the bolus dose. Propofol concentration on termination of infusion was 13 μg/ml; thereafter, propofol concentrations declined less rapidly than after the bolus dose. Waking occurred about 44 min post-infusion. 4. Propofol was cleared by conjugation of the parent molecule or its quinol metabolite; hydroxylation of an isopropyl group also occurred in rat and rabbit. Biliary excretion leading to enterohepatic recirculation, and in turn increased sulphate conjugation, occurred in rat and dog, but not rabbit, resulting in a marked interspecies variation in drug clearance and metabolite profiles.Keywords
This publication has 21 references indexed in Scilit:
- Sulphation and glucuronidation of xamoterol in the dog: Dose dependence and site of sulphationXenobiotica, 1988
- PHARMACOKINETICS OF PROPOFOL IN FEMALE PATIENTSBritish Journal of Anaesthesia, 1987
- DISPOSITION OF PROPOFOL IN PATIENTS UNDERGOING SURGERYBritish Journal of Anaesthesia, 1986
- PHARMACOLOGY OF AN EMULSION FORMULATION OF ICI 35 868British Journal of Anaesthesia, 1984
- PHARMACOKINETIC EVALUATION OF ICI 35 868 IN MANBritish Journal of Anaesthesia, 1983
- The systemic bioavailability of buprenorphine by various routes of administrationJournal of Pharmacy and Pharmacology, 1981
- Estimation of ICI 35,868 (diprivanR) in blood by high-performance liquid chromatography, following coupling with Gibbs' reagentJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agentsJournal of Medicinal Chemistry, 1980
- ANIMAL STUDIES OF THE ANAESTHETIC ACTIVITY OF ICI 35 868British Journal of Anaesthesia, 1980
- Bile and Urine as Complementary Pathways for the Excretion of Foreign Organic CompoundsXenobiotica, 1976